{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:18:41Z","timestamp":1793146721694,"version":"4.5.0"},"reference-count":89,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2019,9,25]]},"abstract":"<jats:sec><jats:title>:<\/jats:title><jats:p>The process of programmed cell death in higher eukaryotes (apoptosis), is generally characterized by distinct morphological characteristics and energy-dependent biochemical mechanisms. Apoptosis is considered as a vital component of various processes including normal cell turnover, proper development and functioning of the immune system, hormone-dependent atrophy, embryonic development and chemical-induced cell death. Apoptosis seems to play an important key role in the progression of several human diseases like Alzheimer's disease, Parkinson's disease and many types of cancer. Promotion of apoptosis may be a good approach for the prevention of cancer cell proliferation. In early studies, antitumor compounds have been found to induce the apoptotic process in tumor cells. On the other hand, several hydrazones were reported to have lower toxicity than hydrazides due to the blockage of \u2013NH2 group. Therefore, the design of hydrazones that activate and promote apoptosis is an attractive strategy for the discovery and development of potential anticancer agents. The aim of this review is to provide a general overview of current knowledge and the connection between apoptosis and hydrazone. It is also the guide for the apoptotic activities of new hydrazone derivatives.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389557519666190410125910","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T14:19:56Z","timestamp":1554905996000},"page":"1427-1442","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Recent Advances in Apoptosis: THE Role of Hydrazones"],"prefix":"10.2174","volume":"19","author":[{"given":"Pelin","family":"\u00c7\u0131kla-S\u00fczg\u00fcn","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Haydapa\u015fa, 34668, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e. G\u00fcniz","family":"K\u00fc\u00e7\u00fckg\u00fczel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Haydapa\u015fa, 34668, \u0130stanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","volume":"26","author":"Kerr J.F.","year":"1972","unstructured":"Kerr J.F.; Wyllie A.H.; Currie A.R.; Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972,26,239-257","journal-title":"Br J Cancer"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/35048077","volume":"2","author":"Paweletz N.","year":"2001","unstructured":"Paweletz N.; Walther Flemming: Pioneer of mitosis research. Nat Rev Mol Cell Biol 2001,2,72-75","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S.","year":"2007","unstructured":"Elmore S.; Apoptosis: A review of programmed cell death. Toxicol Pathol 2007,35(4),495-516","journal-title":"Toxicol Pathol"},{"key":"ref=4","first-page":"1701","volume":"59","author":"Horvitz H.R.","year":"1999","unstructured":"Horvitz H.R.; Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res 1999,59,1701-1706","journal-title":"Cancer Res"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7","volume":"182","author":"Formigli L.","year":"2000","unstructured":"Formigli L.; Papucci L.; Tani A.; Schiavone N.; Tempestini A.; Orlandini G.E.; Capaccioli S.; Orlandini S.Z.; Aponecrosis: morphological and biochemical exploration of a syncreticprocess of cell death sharing apoptosis and necrosis. J Cell Physiol 2000,182,41-49","journal-title":"J Cell Physiol"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"14376","DOI":"10.1073\/pnas.97.26.14376","volume":"97","author":"Sperandio S.","year":"2000","unstructured":"Sperandio S.; de Belle I.; Bredesen D.E.; An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 2000,97,14376-14381","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4161\/auto.1.2.1738","volume":"1","author":"Debnath J.","year":"2005","unstructured":"Debnath J.; Baehrecke E.H.; Kroemer G.; Does autophagy contribute to cell death? Autophagy 2005,1,66-74","journal-title":"Autophagy"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.pharmtox.41.1.367","volume":"41","author":"Norbury C.J.","year":"2001","unstructured":"Norbury C.J.; Hickson I.D.; Cellular responses to DNA damage. Annu Rev Pharmacol Toxicol 2001,41,367-401","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=9","first-page":"5","volume":"Vol. 3","author":"Kerr J.F.R.","year":"1991","unstructured":"Kerr J.F.R.; Harmon B.V.; Definition and incidence of apoptosis: An historical perspective. Apoptosis: The molecular basis of cell death 1991,Vol. 3,5-29","journal-title":"Apoptosis: The molecular basis of cell death"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/bbrc.1999.1888","volume":"266","author":"Fadeel B.","year":"1999","unstructured":"Fadeel B.; Orrenius S.; Zhivotovsky B.; Apoptosis in human disease: A new skin for the old ceremony? Biochem Biophys Res Commun 1999,266,699-717","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/359554a0","volume":"359","author":"Fanidi A.","year":"1992","unstructured":"Fanidi A.; Harrington E.A.; Evan G.I.; Cooperative interaction between c-myc and bcl-2 proto-oncogene. Nature 1992,359,554-556","journal-title":"Nature"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/356397a0","volume":"356","author":"Raff M.C.","year":"1992","unstructured":"Raff M.C.; Social controls on cell survival and cell death. Nature 1992,356,397-400","journal-title":"Nature"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"Evan G.I.","year":"2001","unstructured":"Evan G.I.; Vousden K.H.; Proliferation, cell cycle and apoptosis in cancer. Nature 2001,411,342-348","journal-title":"Nature"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90513-8","volume":"80","author":"Miyashita T.","year":"1995","unstructured":"Miyashita T.; Reed J.C.; Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995,80,293-299","journal-title":"Cell"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.284.5411.156","volume":"284","author":"Soengas M.S.","year":"1999","unstructured":"Soengas M.S.; Alarcon R.M.; Yoshida H.; Giaccia A.J.; Hakem R.; Mak T.W.; Lowe S.W.; Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 1999,284,156-159","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1128\/MCB.15.6.3032","volume":"15","author":"Owen-Schaub L.B.","year":"1995","unstructured":"Owen-Schaub L.B.; Zhang W.; Cusack J.C.; Angelo L.S.; Santee S.M.; Fujiwara T.; Roth J.A.; Deisseroth A.B.; Zhang W.W.; Kruzel E.; Wild-type human p53 and a temperature sensitive mutant induce Fas\/APO-1 expression. Mol Cell Biol 1995,15,3032-3040","journal-title":"Mol Cell Biol"},{"key":"ref=17","first-page":"1593","volume":"58","author":"Sheikh M.S.","year":"1998","unstructured":"Sheikh M.S.; Burns T.F.; Huang Y.; Wu G.S.; Amundson S.; Brooks K.S.; Fornace A.J.; el Deiry W.S.; p53-dependent and -independent regulation of the death receptor KILLER\/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 1998,58,1593-1598","journal-title":"Cancer Res"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"Levine A.J.","year":"1997","unstructured":"Levine A.J.; p53, The cellular gatekeeper for growth and division. Cell 1997,88,323-331","journal-title":"Cell"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1006\/scbi.1998.0095","volume":"8","author":"Schwartz D.","year":"1998","unstructured":"Schwartz D.; Rotter V.; p53-dependent cell cycle control: response to genotoxic stress. Semin Cancer Biol 1998,8,325-336","journal-title":"Semin Cancer Biol"},{"key":"ref=20","first-page":"55","volume":"19","author":"Ak\u015fit H.","year":"2008","unstructured":"Ak\u015fit H.; Bildik A.; Apoptozis, YY\u00dc Vet. Fak Derg 2008,19,55-63","journal-title":"Fak Derg"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/75007","volume":"6","author":"Teitz T.","year":"2000","unstructured":"Teitz T.; Wei T.; Valentine M.B.; Vanin E.F.; Grenet J.; Valentine V.A.; Behm F.G.; Look A.T.; Lahti J.M.; Kidd V.J.; Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 2000,6,529-535","journal-title":"Nat Med"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1158\/0008-5472.815.65.3","volume":"65","author":"Soung Y.H.","year":"2005","unstructured":"Soung Y.H.; Lee J.W.; Kim S.Y.; Jang J.; Park Y.G.; Park W.S.; Nam S.W.; Lee J.Y.; Yoo N.J.; Lee S.H.; Caspase-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 2005,65,815-821","journal-title":"Cancer Res"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","volume":"396","author":"Li F.","year":"1998","unstructured":"Li F.; Ambrosini G.; Chu E.Y.; Plescia J.; Tognin S.; Marchisio P.C.; Altieri D.C.; Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998,396,580-584","journal-title":"Nature"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.bjc.6602340","volume":"92","author":"Li F.","year":"2005","unstructured":"Li F.; Role of survivin and its splice variants in tumorigenesis. Br J Cancer 2005,92,212-216","journal-title":"Br J Cancer"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.0.CO;2-5","volume":"60","author":"Reed J.C.","year":"1996","unstructured":"Reed J.C.; Miyashita T.; Takayama S.; Wang H.G.; Sato T.; Krajewski S.; Aime S.C.; Bodrug S.; Kitada S.; Hanada M.; BcL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem 1996,60,23-32","journal-title":"J Cell Biochem"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","volume":"83","author":"Tsujii M.","year":"1995","unstructured":"Tsujii M.; DuBois R.N.; Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995,83(3),493-501","journal-title":"Cell"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/jhep.2002.36125","volume":"36","author":"Thesis Kern M.A.","year":"2002","unstructured":"Thesis Kern M.A.; Schubert D.; Sahi D.; Sch\u00f6neweiss M.M.; Moll I.; Haugg A.M.; Dienes H.P.; Breuhahn K.; Schirmacher P.; Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Hepatology 2002,36,885-894","journal-title":"Hepatology"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/74994","volume":"6","author":"Kroemer G.","year":"2000","unstructured":"Kroemer G.; Reed J.C.; Mitochondrial control of cell death. Nat Med 2000,6,513-519","journal-title":"Nat Med"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00280-004-0944-5","volume":"56","author":"Fahy B.N.","year":"2005","unstructured":"Fahy B.N.; Schlieman M.G.; Mortenson M.M.; Virudachalam S.; Bold R.J.; Targeting BcL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol 2005,56,46-54","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ardp.201200449","volume":"346","author":"\u00c7\u0131kla P.","year":"2013","unstructured":"\u00c7\u0131kla P.; \u00d6zsavc\u0131 D.; Bing\u00f6l-\u00d6zakp\u0131nar \u00d6.; \u015eener A.; \u00c7evik \u00d6.; \u00d6zba\u015f-Turan S.; Akbu\u011fa J.; \u015eahin F.; K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents. Arch Pharm (Weinheim) 2013,346(5),367-379","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/15701808113109990069","volume":"11","author":"Ayd\u0131n S.","year":"2014","unstructured":"Ayd\u0131n S.; Kaushik-Basu N.; \u00d6zba\u015f-Turan S.; Akbu\u011fa J.; Mega Tiber P.; Orun O.; Gurukumar K.R.; Basu A.; K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; Synthesis of 1-aroyl-3,5-dimethyl-1H-pyrazoles as anti-HCV and anticancer agent. Lett Drug Des Discov 2014,11,121-131","journal-title":"Lett Drug Des Discov"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/12081910","volume":"12","author":"Rollas S.","year":"2007","unstructured":"Rollas S.; K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; Biological activities of hydrazone derivatives. Molecules 2007,12,1910-1939","journal-title":"Molecules"},{"key":"ref=33","first-page":"255","volume":"67","author":"Deep A.","year":"2010","unstructured":"Deep A.; Jain S.; Sharma P.C.; Verma P.; Kumar M.; Dora C.P.; Design and biological evaluation of biphenyl-4-carboxylic acid hydrazide-hydrazone for antimicrobial activity. Acta Pol Pharm 2010,67(3),255-259","journal-title":"Acta Pol Pharm"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/jm00261a027","volume":"16","author":"Szarvasi E.","year":"1973","unstructured":"Szarvasi E.; Fontaine L.; Betbeder-Matibet A.; Antimicrobials. New nitrofuran derivatives. J Med Chem 1973,16(3),281-287","journal-title":"J Med Chem"},{"key":"ref=35","first-page":"67","volume":"2","author":"Turan-Zitouni G.","year":"1998","unstructured":"Turan-Zitouni G.; Kaplanc\u0131kl\u0131 Z.A.; 5-Acetylindan aryloxyacetohydrazone derivatives: Synthesis and antituberculosis activity. Acta Pharm Turc 1998,2,67-71","journal-title":"Acta Pharm Turc"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"8675","DOI":"10.1016\/j.bmc.2006.08.022","volume":"14","author":"Metwally K.A.","year":"2006","unstructured":"Metwally K.A.; Abdel-Aziz L.M.; Lashine E.M.; Husseiny M.I.; Badawy R.H.; Hydrazones of 2-aryl-quinoline-4-carboxylic acid hydrazides: Synthesis and preliminary evaluation as antimicrobial agents. Bioorg Med Chem 2006,14(24),8675-8682","journal-title":"Bioorg Med Chem"},{"key":"ref=37","first-page":"993","volume":"42","author":"Singh V.","year":"1992","unstructured":"Singh V.; Srivastava V.K.; Palit G.; Shanker K.; Coumarin congeners as antidepressants. Arzneim-Forsch Drug Res 1992,42(8),993-999","journal-title":"Arzneim-Forsch Drug Res"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ijc.1427","volume":"94","author":"Easmon J.","year":"2001","unstructured":"Easmon J.; Puerstinger G.; Roth T.; Fiebig H.H.; Jenny M.; Jaeger W.; Heinisch G.; Hofmann J.; 2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine: A novel class of antitumor agents. Int J Cancer 2001,94,89-96","journal-title":"Int J Cancer"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.yexcr.2004.06.024","volume":"299","author":"De Graaf A.O.","year":"2004","unstructured":"De Graaf A.O.; Van den Heuvel L.P.; Dijkman H.B.; De Abreu R.A.; Birkenkamp K.U.; De Witte T.; Van der Reijden B.A.; Smeitink J.A.; Jansen J.H.; BcL-2 prevents loss of mitochondria in CCCP-induced apoptosis. Exp Cell Res 2004,299(2),533-540","journal-title":"Exp Cell Res"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.bmc.2004.04.017","volume":"12","author":"Zhang H.Z.","year":"2004","unstructured":"Zhang H.Z.; Drewe J.; Tseng B.; Kasibhatla S.; Cai S.X.; Discovery and SAR of indole-2-carboxylic acid benzylidene-hydrazides as a new series of potent apoptosis inducers using a cell-based HTS assay. Bioorg Med Chem 2004,12(13),3649-3655","journal-title":"Bioorg Med Chem"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nchembio814","volume":"2","author":"Putt K.S.","year":"2006","unstructured":"Putt K.S.; Chen G.W.; Pearson J.M.; Sandhorst J.S.; Hoagland M.S.; Kwon J.T.; Hwang S.K.; Jin H.; Churchwell M.I.; Cho M.H.; Doerge D.R.; Helferich W.G.; Hergenrother P.J.; Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy. Nat Chem Biol 2006,2(10),543-550","journal-title":"Nat Chem Biol"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2010.07.002","volume":"247","author":"Aziz G.","year":"2010","unstructured":"Aziz G.; Akselsen \u00d8.W.; Hansen T.V.; Paulsen R.E.; Procaspase-activating compound 1 induces a caspase-3-dependent cell death in cerebellar granule neurons. Toxicol Appl Pharmacol 2010,247(3),238-242","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1158\/0008-5472.CAN-10-0766","volume":"70","author":"Peterson Q.P.","year":"2010","unstructured":"Peterson Q.P.; Hsu D.C.; Novotny C.J.; West D.C.; Kim D.; Schmit J.M.; Dirikolu L.; Hergenrother P.J.; Fan T.M.; Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound. Cancer Res 2010,70,7232-7241","journal-title":"Cancer Res"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm900722z","volume":"52","author":"Peterson Q.P.","year":"2009","unstructured":"Peterson Q.P.; Hsu D.C.; Goode D.R.; Novotny C.J.; Totten R.K.; Hergenrother P.J.; Procaspase-3 activation as an anti-cancer strategy: Structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co-localization with caspase-3. J Med Chem 2009,52(18),5721-5731","journal-title":"J Med Chem"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.bmc.2008.04.071","volume":"16","author":"Vogel S.","year":"2008","unstructured":"Vogel S.; Kaufmann D.; Pojarov\u00e1 M.; M\u00fcller C.; Pfaller T.; K\u00fchne S.; Bednarski P.J.; Von Angerer E.; Aroyl hydrazones of 2-phenylindole-3-carbaldehydes as novel antimitotic agents. Bioorg Med Chem 2008,16(12),6436-6447","journal-title":"Bioorg Med Chem"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.bmc.2009.01.037","volume":"17","author":"Zheng L.W.","year":"2009","unstructured":"Zheng L.W.; Wu L.L.; Zhao B.X.; Dong W.L.; Miao J.Y.; Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Bioorg Med Chem 2009,17(5),1957-1962","journal-title":"Bioorg Med Chem"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1248\/cpb.58.1324","volume":"58","author":"Zhao Y.","year":"2010","unstructured":"Zhao Y.; Hui J.; Wang D.; Zhu L.; Fang J.H.; Zhao X.D.; Synthesis, cytotoxicity and pro-apoptosis of novel benzoisoindolin hydrazones as anticancer agents. Chem Pharm Bull (Tokyo) 2010,58(10),1324-1327","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3892\/etm_00000058","volume":"2","author":"Wirries A.","year":"2010","unstructured":"Wirries A.; Breyer S.; Quint K.; Schobert R.; Ocker M.; Thymoquinone hydrazone derivatives cause cell cycle arrest in p53-competent colorectal cancer cells. Exp Ther Med 2010,2,369-375","journal-title":"Exp Ther Med"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"485","DOI":"10.5414\/CPP48485","volume":"48","author":"Effenberger K.","year":"2010","unstructured":"Effenberger K.; Breyer S.; Ocker M.; Schobert R.; New doxorubicin N-acyl hydrazones with improved efficacy and cell line specificity show modes of action different from the parent drug. Int J Clin Pharmacol Ther 2010,48(7),485-486","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ejmech.2010.01.037","volume":"45","author":"Effenberger K.","year":"2010","unstructured":"Effenberger K.; Breyer S.; Schobert R.; Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazones. Eur J Med Chem 2010,45(5),1947-1954","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1021\/jf2017594","volume":"59","author":"Bak Y.","year":"2011","unstructured":"Bak Y.; Kim H.; Kang J.W.; Lee D.H.; Kim M.S.; Park Y.S.; Kim J.H.; Jung K.Y.; Lim Y.; Hong J.; Yoon D.Y.; A synthetic naringenin derivative, 5-hydroxy-7,4\u2032-diacetyloxyflavanone-N-phenyl hydrazone (N101-43), induces apoptosis through up-regulation of Fas\/FasL expression and inhibition of PI3K\/Akt signaling pathways in non-small-cell lung cancer cells. J Agric Food Chem 2011,59(18),10286-102897","journal-title":"J Agric Food Chem"},{"key":"ref=52","first-page":"259","volume":"12","author":"Zulkepli N.A.","year":"2011","unstructured":"Zulkepli N.A.; Rou K.V.; Sulaiman W.N.; Salhin A.; Saad B.; Seeni A.; A synthetic hydrazone derivative acts as an apoptotic inducer with chemopreventive activity on a tongue cancer cell line. Asian Pac J Cancer Prev 2011,12,259-263","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=53","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1016\/j.bmcl.2011.09.061","volume":"21","author":"Lou J.","year":"2011","unstructured":"Lou J.; Liu Z.; Li Y.; Zhou M.; Zhang Z.; Zheng S.; Wang R.; Li J.; Synthesis and anti-tumor activities of N\u2032-benzylidene-2-(4-oxothieno[2,3-d]pyrimidin-3(4H)-yl)acetohydrazone derivatives. Bioorg Med Chem Lett 2011,21(22),6662-6666","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=54","first-page":"2863","volume":"30","author":"Han Y.H.","year":"2010","unstructured":"Han Y.H.; Yang Y.M.; Park W.H.; Carbonyl cyanide p-(trifluoromethoxy) phenylhydroazone induces caspase-independent apoptosis in As4.1 juxtaglomerular cells. Anticancer Res 2010,30(7),2863-2868","journal-title":"Anticancer Res"},{"key":"ref=55","first-page":"575","volume":"27","author":"Han Y.H.","year":"2011","unstructured":"Han Y.H.; Park W.H.; Intracellular glutathione levels are involved in carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone-induced apoptosis in As4.1 juxtaglomerular cells. Int J Mol Med 2011,27(4),575-581","journal-title":"Int J Mol Med"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1016\/j.bmc.2011.09.036","volume":"19","author":"Hassan G.S.","year":"2011","unstructured":"Hassan G.S.; Kadry H.H.; Abou-Seri S.M.; Ali M.M.; Mahmoud A.E.; Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line. Bioorg Med Chem 2011,19(22),6808-6817","journal-title":"Bioorg Med Chem"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/jcb.23118","volume":"112","author":"Quattrocelli M.","year":"2011","unstructured":"Quattrocelli M.; Palazzolo G.; Agnolin I.; Martino S.; Bouch\u00e9 M.; Anastasia L.; Sampaolesi M.; Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells. J Cell Biochem 2011,112(8),2006-2014","journal-title":"J Cell Biochem"},{"key":"ref=58","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.bmcl.2012.03.060","volume":"22","author":"Dandawate P.","year":"2012","unstructured":"Dandawate P.; Khan E.; Padhye S.; Gaba H.; Sinha S.; Deshpande J.; Venkateswara S.K.; Khetmalas M.; Ahmad A.; Sarkar F.H.; Synthesis, characterization, molecular docking and cytotoxic activity of novel plumbagin hydrazones against breast cancer cells. Bioorg Med Chem Lett 2012,22(9),3104-3108","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.tiv.2011.10.012","volume":"26","author":"Kim J.H.","year":"2012","unstructured":"Kim J.H.; Kang J.W.; Kim M.S.; Bak Y.; Park Y.S.; Jung K.Y.; Lim Y.H.; Yoon D.Y.; The apoptotic effects of the flavonoid N101-2 in human cervical cancer cells. Toxicol In Vitro 2012,26,67-73","journal-title":"Toxicol In Vitro"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/1078-0432.CCR-11-0579","volume":"18","author":"Trisciuoglio D.","year":"2012","unstructured":"Trisciuoglio D.; Ragazzoni Y.; Pelosi A.; Desideri M.; Carradori S.; Gabellini C.; Maresca G.; Nescatelli R.; Secci D.; Bolasco A.; Bizzarri B.; Cavaliere C.; D\u2019Agnano I.; Filetici P.; Ricci-Vitiani L.; Rizzo M.G.; Del Bufalo D.; CPTH6, A thiazole derivative, induces histone hypoacetylation and apoptosis in human leukemia cells. Clin Cancer Res 2012,18(2),475-486","journal-title":"Clin Cancer Res"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00044-011-9703-4","volume":"21","author":"\u0141azarenkow A.","year":"2012","unstructured":"\u0141azarenkow A.; Nawrot-Modranka J.; Brzezi\u0144ska E.; Krajewska U.; R\u00f3\u017calski M.; Synthesis, preliminary cytotoxicity evaluation of new 3-formylchromone hydrazones and phosphorohydrazone derivatives of coumarin and chromone. Med Chem Res 2012,21(8),1861-1868","journal-title":"Med Chem Res"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/aps.2011.158","volume":"33","author":"Shi Z.Y.","year":"2012","unstructured":"Shi Z.Y.; Li Y.Q.; Kang Y.H.; Hu G.Q.; Huang-fu C.S.; Deng J.B.; Liu B.; Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells. Acta Pharmacol Sin 2012,33(2),271-278","journal-title":"Acta Pharmacol Sin"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10637-010-9560-x","volume":"30","author":"Moktan S.","year":"2012","unstructured":"Moktan S.; Ryppa C.; Kratz F.; Raucher D.; A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis. Invest New Drugs 2012,30,236-248","journal-title":"Invest New Drugs"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejmech.2012.01.051","volume":"50","author":"Despaigne A.A.","year":"2012","unstructured":"Despaigne A.A.; Parrilha G.L.; Izidoro J.B.; da Costa P.R.; dos Santos R.G.; Piro O.E.; Castellano E.E.; Rocha W.R.; Beraldo H.; 2-Acetylpyridine- and 2-benzoylpyridine-derived hydrazones and their gallium(III) complexes are highly cytotoxic to glioma cells. Eur J Med Chem 2012,50,163-172","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/and.12429","volume":"48","author":"Sar\u0131\u00f6zkan S.","year":"2016","unstructured":"Sar\u0131\u00f6zkan S.; T\u00fcrk G.; \u00c7\u0131kla-S\u00fczg\u00fcn P.; G\u00fcven\u00e7 M.; Y\u00fcce A.; Yay A.H.; Cant\u00fcrk F.; K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; Effect of etodolac hydrazone, a new compound synthesised from etodolac, on spermatozoon quality, testicular lipid peroxidation, apoptosis and spermatozoon DNA integrity. Andrologia 2016,48(2),177-188","journal-title":"Andrologia"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/mabi.201200441","volume":"13","author":"Zhang Y.","year":"2013","unstructured":"Zhang Y.; Xiao C.; Li M.; Chen J.; Ding J.; He C.; Zhuang X.; Chen X.; Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. Macromol Biosci 2013,13(5),584-594","journal-title":"Macromol Biosci"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1475-2867-13-67","volume":"13","author":"Sun J.P.","year":"2013","unstructured":"Sun J.P.; Shi Z.Y.; Liu S.M.; Kang Y.H.; Hu G.Q.; Huangfu C.S.; Deng J.B.; Liu B.; Trimethoxy-benzaldehyde levofloxacin hydrazone inducing the growth arrest and apoptosis of human hepatocarcinoma cells. Cancer Cell Int 2013,13,67-77","journal-title":"Cancer Cell Int"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1021\/jm400556w","volume":"56","author":"Sleebs B.E.","year":"2013","unstructured":"Sleebs B.E.; Kersten W.J.; Kulasegaram S.; Nikolakopoulos G.; Hatzis E.; Moss R.M.; Parisot J.P.; Yang H.; Czabotar P.E.; Fairlie W.D.; Lee E.F.; Adams J.M.; Chen L.; van Delft M.F.; Lowes K.N.; Wei A.; Huang D.C.; Colman P.M.; Street I.P.; Baell J.B.; Watson K.; Lessene G.; Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL. J Med Chem 2013,56(13),5514-5540","journal-title":"J Med Chem"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejmech.2014.02.026","volume":"76","author":"Nasr T.","year":"2014","unstructured":"Nasr T.; Bondock S.; Youns M.; Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur J Med Chem 2014,76,539-548","journal-title":"Eur J Med Chem"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00044-013-0717-y","volume":"23","author":"Kaplanc\u0131kl\u0131 Z.A.","year":"2014","unstructured":"Kaplanc\u0131kl\u0131 Z.A.; Yurtta\u015f L.; \u00d6zdemir A.; Turan-Zitouni G.; Akal\u0131n \u00c7ift\u00e7i G.; Ulusoylar Y\u0131ld\u0131r\u0131m \u015e.; Abu Mohsen U.; Synthesis and antiproliferative activity of new 1,5-disubstituted tetrazoles bearing hydrazone moiety. Med Chem Res 2014,23,1067-1075","journal-title":"Med Chem Res"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ejmech.2014.04.042","volume":"80","author":"Carradori S.","year":"2014","unstructured":"Carradori S.; Rotili D.; De Monte C.; Lenoci A.; D\u2019Ascenzio M.; Rodriguez V.; Filetici P.; Miceli M.; Nebbioso A.; Altucci L.; Secci D.; Mai A.; Evaluation of a large library of (thiazol-2-yl)hydrazones and analogues as histone acetyltransferase inhibitors: enzyme and cellular studies. Eur J Med Chem 2014,80,569-578","journal-title":"Eur J Med Chem"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ardp.201500178","volume":"348","author":"K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.","year":"2015","unstructured":"K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; Ko\u00e7 D.; \u00c7\u0131kla-S\u00fczg\u00fcn P.; \u00d6zsavc\u0131 D.; Bing\u00f6l-\u00d6zakp\u0131nar \u00d6.; Mega-Tiber P.; Orun O.; Erzincan P.; Sa\u011f-Erdem S.; \u015eahin F.; Synthesis of tolmetin hydrazide-hydrazones and discovery of a potent apoptosis \u0131nducer in colon cancer cells. Arch Pharm (Weinheim) 2015,348(10),730-742","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1016\/j.bmcl.2015.06.084","volume":"25","author":"Paterna A.","year":"2015","unstructured":"Paterna A.; Borralho P.M.; Gomes S.E.; Mulhovo S.; Rodrigues C.M.; Ferreira M.J.; Monoterpene indole alkaloid hydrazone derivatives with apoptosis inducing activity in human HCT116 colon and HepG2 liver carcinoma cells. Bioorg Med Chem Lett 2015,25(17),3556-3559","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.steroids.2015.01.002","volume":"95","author":"Cui J.","year":"2015","unstructured":"Cui J.; Liu L.; Zhao D.; Gan C.; Huang X.; Xiao Q.; Qi B.; Yang L.; Huang Y.; Synthesis, characterization and antitumor activities of some steroidal derivatives with side chain of 17-hydrazone aromatic heterocycle. Steroids 2015,95,32-38","journal-title":"Steroids"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1016\/j.bmcl.2015.08.022","volume":"25","author":"Zawawi N.K.","year":"2015","unstructured":"Zawawi N.K.; Rajput S.A.; Taha M.; Ahmat N.; Ismail N.H.; Abdullah N.; Khan K.M.; Choudhary M.I.; Benzimidazole derivatives protect against cytokine-induced apoptosis in pancreatic \u03b2-Cells. Bioorg Med Chem Lett 2015,25(20),4672-4676","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejmech.2015.10.041","volume":"108","author":"\u015eenkarde\u015f S.","year":"2016","unstructured":"\u015eenkarde\u015f S.; Kaushik-Basu N.; Durmaz \u0130.; Manvar D.; Basu A.; Atalay R.; K\u00fc\u00e7\u00fckg\u00fczel \u015e.G.; Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. Eur J Med Chem 2016,108,301-308","journal-title":"Eur J Med Chem"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2016.05.010","volume":"120","author":"Kamath P.R.","year":"2016","unstructured":"Kamath P.R.; Sunil D.; Ajees A.A.; Pai K.S.; \u2032 Biswas S.N; -((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)-benzohydrazide as a probable Bcl-2\/Bcl-xL inhibitor with apoptotic and anti-metastatic potential. Eur J Med Chem 2016,120,134-147","journal-title":"Eur J Med Chem"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1021\/acs.biochem.5b01127","volume":"55","author":"Das Mukherjee D.","year":"2016","unstructured":"Das Mukherjee D.; Kumar N.M.; Tantak M.P.; Das A.; Ganguli A.; Datta S.; Kumar D.; Chakrabarti G.; Development of novel bis(indolyl)-hydrazide-hydrazone derivatives as potent microtubule-targeting cytotoxic agents against A549 lung cancer cells. Biochemistry 2016,55(21),3020-3035","journal-title":"Biochemistry"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.bmcl.2016.05.059","volume":"26","author":"He H.","year":"2016","unstructured":"He H.; Wang X.; Shi L.; Yin W.; Yang Z.; He H.; Liang Y.; Synthesis, antitumor activity and mechanism of action of novel 1,3-thiazole derivatives containing hydrazide-hydrazone and carboxamide moiety. Bioorg Med Chem Lett 2016,26(14),3263-3270","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jsbmb.2017.07.031","volume":"174","author":"\u017divkovi\u0107 M.B.","year":"2017","unstructured":"\u017divkovi\u0107 M.B.; Mati\u0107 I.Z.; Rodi\u0107 M.V.; Novakovi\u0107 I.T.; Krivoku\u0107a A.M.; Sladi\u0107 D.M.; Krsti\u0107 N.M.; Anticancer potential of new steroidal thiazolidin-4-one derivatives. Mechanisms of cytotoxic action and effects on angiogenesis in vitro. J Steroid Biochem Mol Biol 2017,174,72-85","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ejmech.2016.10.022","volume":"124","author":"Li Z.H.","year":"2016","unstructured":"Li Z.H.; Yang D.X.; Geng P.F.; Zhang J.; Wei H.M.; Hu B.; Guo Q.; Zhang X.H.; Guo W.G.; Zhao B.; Yu B.; Ma L.Y.; Liu H.M.; Design, synthesis and biological evaluation of [1,2,3]triazolo[4,5-d]pyrimidine derivatives possessing a hydrazone moiety as antiproliferative agents. Eur J Med Chem 2016,124,967-980","journal-title":"Eur J Med Chem"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmech.2017.09.009","volume":"140","author":"Gazieva G.A.","year":"2017","unstructured":"Gazieva G.A.; Anikina L.V.; Nechaeva T.V.; Pukhov S.A.; Karpova T.B.; Popkov S.V.; Nelyubina Y.V.; Kolotyrkina N.G.; Kravchenko A.N.; Synthesis and biological evaluation of new substituted thioglycolurils, their analogues and derivatives. Eur J Med Chem 2017,140,141-154","journal-title":"Eur J Med Chem"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bioorg.2017.10.016","volume":"76","author":"Labib M.B.","year":"2018","unstructured":"Labib M.B.; Philoppes J.N.; Lamie P.F.; Ahmed E.R.; Azole-hydrazone derivatives: Design, synthesis, in vitro biological evaluation, dual EGFR\/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents. Bioorg Chem 2018,76,67-80","journal-title":"Bioorg Chem"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","volume":"35","author":"Elmore S.","year":"2007","unstructured":"Elmore S.; Apoptosis: A review of programmed cell death. Toxicol Pathol 2007,35(4),495-516","journal-title":"Toxicol Pathol"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cbf.1774","volume":"29","author":"Ulukaya E.","year":"2011","unstructured":"Ulukaya E.; Acilan C.; Yilmaz Y.; Apoptosis: why and how does it occur in biology? Cell Biochem Funct 2011,29(6),468-480","journal-title":"Cell Biochem Funct"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/1940-6207.CAPR-14-0136","volume":"7","author":"Millimouno F.M.","year":"2014","unstructured":"Millimouno F.M.; Dong J.; Yang L.; Li J.; Li X.; Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature. Cancer Prev Res (Phila) 2014,7(11),1081-1107","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.steroids.2014.06.003","volume":"90C","author":"Obiorah I.E.","year":"2014","unstructured":"Obiorah I.E.; Fan P.; Sengupta S.; Jordan V.C.; Selective estrogen-induced apoptosis in breast cancer. Steroids 2014,90C,60-70","journal-title":"Steroids"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jcb.24709","volume":"115","author":"Gillies L.A.","year":"2014","unstructured":"Gillies L.A.; Kuwana T.; Apoptosis regulation at the mitochondrial outer membrane. J Cell Biochem 2014,115(4),632-640","journal-title":"J Cell Biochem"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1517\/13543776.2014.877445","volume":"24","author":"Kamal A.","year":"2014","unstructured":"Kamal A.; Faazil S.; Malik M.S.; Apoptosis-inducing agents: A patent review (2010-2013). Expert Opin Ther Pat 2014,24(3),339-354","journal-title":"Expert Opin Ther Pat"}],"container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/171509","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T18:03:27Z","timestamp":1663265007000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/171509\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,25]]},"references-count":89,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,9,25]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557519666190410125910","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,25]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-07-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}